Buy Fluetonitazene (benzimidazole) Cas 74457-86-6

Fluetonitazene (fluornitrazene, F-etonitazene, 2-fluoroetonitazene) is a benzimidazole derivative which is an opioid designer drug. It was patented in 2024 as a potential novel analgesic,^[1] but appeared on the illicit market at around the same time, first being identified in Germany in March 2024.^[2][3] It is a potent opioid agonist in vitro with similar potency to N-Desethyletonitazene.^[4]

• Fluetonitazepyne
• Isotonitazene
• Protonitazene
• List of benzimidazole opioids